Professor | Zhongfang Wang | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Zhongfang Wang
Contact Information	wangzhongfang@gird.cn
Language ability	Chinese, English
Province	Guangdong

Upload Avatar (500 x 500)

Name

Zhongfang Wang

Contact Information

wangzhongfang@gird.cn

Language ability

Chinese, English

Province

Guangdong

University/Lab Affiliation and Title	Guangzhou Medical University
Faculty	Basic Medical Sciences
Awards	National High-Level Talent Special Support Plan (2023): Detail Pearl River Scholar Distinguished Professor (2019): Detail Guangzhou High-Level Talent (Outstanding Expert) (2019): Detail Ministry of Human Resources and Social Security High-Level Overseas Talent (2020): Detail

University/Lab Affiliation and Title

Guangzhou Medical University

Faculty

Basic Medical Sciences

Awards

National High-Level Talent Special Support Plan (2023): Detail
Pearl River Scholar Distinguished Professor (2019): Detail
Guangzhou High-Level Talent (Outstanding Expert) (2019): Detail
Ministry of Human Resources and Social Security High-Level Overseas Talent (2020): Detail

Areas of Focus	Major respiratory infections and lung injury Immune mechanisms of new/emerging infectious diseases, development and evaluation of immunoprophylaxis technologies T-cell immunity in acute infections and tumors
Publications	Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trial., Co-corresponding author, 2023 SARS-CoV-2 vaccination-infection pattern imprints and diversifies T cell differentiation and neutralizing response against Omicron subvariants., Corresponding author, 2022 SARS-CoV-2-specific CD4+ T cells are associated with long-term persistence of neutralizing antibodies., First author, 2022 Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection., First author, 2021 Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease., First author, 2018

Areas of Focus

Major respiratory infections and lung injury
Immune mechanisms of new/emerging infectious diseases, development and evaluation of immunoprophylaxis technologies
T-cell immunity in acute infections and tumors

Publications

Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trial., Co-corresponding author, 2023
SARS-CoV-2 vaccination-infection pattern imprints and diversifies T cell differentiation and neutralizing response against Omicron subvariants., Corresponding author, 2022
SARS-CoV-2-specific CD4+ T cells are associated with long-term persistence of neutralizing antibodies., First author, 2022
Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection., First author, 2021
Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease., First author, 2018

Respiratory Infections Lung Injury Immune Mechanisms Infectious Diseases Immunoprophylaxis T-Cell Immunity Acute Infections Tumors Vaccine Development Immune Response

Feifei Wang - Fudan University

Gaoqian Feng - Nanjing Medical University

Tan Yurong - Central South University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us